ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

2 Day Aseptic Processing and Validation Course: FDA Expectations and Industry Best Practices (ONLINE: Oct 20th - Oct 21st, 2025) - ResearchAndMarkets.com

The "Aseptic Processing and Validation Course - FDA Expectations and Industry Best Practices (Oct 20th - Oct 21st, 2025)" training has been added to ResearchAndMarkets.com's offering.

This course provides an in-depth review of process design, contamination control strategy, risk assessments, and validation approaches aligned with FDA's Guidance for Industry, EU Annex 1, and ICH Q9/Q10 principles. Participants will gain tools for managing deviations, responding to FDA observations, and implementing effective CAPAs in aseptic environments.

Aseptic processing is one of the most critical and tightly regulated operations in pharmaceutical manufacturing. This 2-day advanced course explores FDA expectations and industry best practices for aseptic technique, facility design, personnel qualification, environmental monitoring, and media fill validation. With increasing scrutiny from FDA and global regulators, companies must demonstrate that their aseptic operations consistently produce sterile product under strict control.

Why You Should Attend:

Aseptic processing failures have led to some of the most severe FDA enforcement actions in recent years - including 483s, Warning Letters, and product recalls. This course is essential for anyone responsible for sterile product manufacturing, quality assurance, validation, or inspection readiness.

Attendees will learn how to mitigate risks through proper gowning, material transfer, environmental control, and process simulation. Emphasis will be placed on process validation strategies, cleanroom behavior, air handling systems, and microbial contamination control. Through practical examples and case studies, the training reinforces how to implement compliant, inspection-ready aseptic practices that ensure product quality and patient safety.

Who Should Attend:

  • Quality Assurance Departments
  • Quality Control Departments
  • Manufacturing (Sterile/Parenteral) Departments
  • Operations Departments
  • Engineering Departments
  • Aseptic Manufacturing Supervisors
  • Regulatory Affairs Departments
  • Validation Engineers
  • Microbiologists
  • Sterility Assurance Professionals
  • Environmental Monitoring Technicians
  • Site Heads and Plant Directors
  • Compliance Departments

Key Topics Covered:

DAY 1

Fundamentals of Aseptic Processing

  • Definitions: aseptic vs sterile vs terminal sterilization
  • Regulatory requirements (FDA, EU Annex 1, WHO)
  • Cleanroom classification and facility design
  • Personnel training and gowning qualifications
  • Material and equipment flow
  • Critical utilities: HVAC, HEPA, compressed gas
  • Contamination control strategy
  • Environmental monitoring program (EM, alert/action levels, trending)
  • Cleanroom behavior and aseptic technique
  • Case studies of FDA 483s related to aseptic failures

DAY 2

Validation and Ongoing Compliance

  • Process simulation/media fill validation
  • Qualification of personnel (initial and ongoing)
  • Cleanroom qualification and air pattern visualization
  • Process validation stages (PPQ) for aseptic products
  • Smoke studies: purpose and execution
  • Risk assessments (FMEA) in aseptic operations
  • Deviation handling and root cause analysis
  • CAPA for aseptic issues
  • Requalification and change management
  • Inspection readiness and responding to FDA findings

Speaker

Meredith Crabtree has over 30 years' experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting is s a Quality Consultant specializing in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.

For more information about this training visit https://www.researchandmarkets.com/r/o7a0qt

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.40
+3.99 (1.63%)
AAPL  269.32
+0.85 (0.32%)
AMD  245.61
+12.07 (5.17%)
BAC  53.69
+0.48 (0.91%)
GOOG  291.26
+11.56 (4.13%)
META  632.88
+11.16 (1.80%)
MSFT  506.46
+9.64 (1.94%)
NVDA  198.13
+9.98 (5.30%)
ORCL  239.35
+0.09 (0.04%)
TSLA  446.19
+16.67 (3.88%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.